PTCT NASDAQ
PTC Therapeutics, Inc.
1W: -0.8%
1M: -2.5%
3M: -19.0%
YTD: -20.4%
1Y: -8.6%
3Y: +159.1%
5Y: +63.4%
$62.09
+1.02 (+1.67%)
After Hours: $62.49 (+0.40, +0.65%)
Weekly Expected Move ±5.7%
$54
$57
$61
$64
$68
Credit Risk of going bust: lower than 68% of companies Debt: 12.0% of company value Bonds: $48.8M held by 18 funds → details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.66 (down 99%), PTC Therapeutics, Inc. would be worth roughly what it owes.
Total debt $696.5M against a stock market value of $5.10B.
Distance to default 7.29 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $323.2M (short-term plus half of long-term), stock volatility 40.6%; Altman Z'' 1.03. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.
If the stock fell to about $0.66 (down 99%), PTC Therapeutics, Inc. would be worth roughly what it owes.
Total debt $696.5M against a stock market value of $5.10B.
Distance to default 7.29 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $323.2M (short-term plus half of long-term), stock volatility 40.6%; Altman Z'' 1.03. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$1B
Revenue
-42.8% YoY
$-38M
Net Income
-106.1% YoY
$-80M
Free Cash Flow
-111.7% YoY
94.5%
Gross Margin
41.3%
Op. Margin
23.2%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE20.6%
ROA-1.3%
ROIC-5.4%
Valuation
P/E-126.1
P/B-31.0
EV/EBITDA34.4
Leverage
Debt/Equity-4.21
Current Ratio3.39
Interest Cov.0.6x
Quality Scores
Piotroski F2/9
Altman Z1.19
Beneish M-1.54